Autolus Therapeutics plc Variable Lease, Cost
Autolus Therapeutics plc (AUTL) reported Variable Lease, Cost of $779.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-11
- Autolus Therapeutics plc variable lease, cost for the quarter ending 2026-06-30 was $779.00K, a 204.30% increase year-over-year.
- Autolus Therapeutics plc variable lease, cost for the quarter ending 2026-03-31 was $420.00K, a 15.32% decline year-over-year.
- Autolus Therapeutics plc variable lease, cost for the quarter ending 2025-09-30 was $676.00K, a 330.57% increase year-over-year.
- Autolus Therapeutics plc variable lease, cost for the quarter ending 2025-06-30 was $256.00K, a 47.11% decline year-over-year.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month |
|---|---|---|---|
| 2026-06-30 | $779.00K 10-Q · filed 2026-08-11 | $1.20M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $420.00K 10-Q · filed 2026-05-14 | ||
| 2025-09-30 | $676.00K 10-Q · filed 2025-11-12 | $932.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.43M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $256.00K 10-Q · filed 2026-08-11 | $752.00K 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $496.00K 10-Q · filed 2026-05-14 | ||
| 2024-09-30 | $157.00K 10-Q · filed 2025-11-12 | $641.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.19M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $484.00K 10-Q · filed 2025-08-12 | $1.03M 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $544.00K 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 |